AuntMinnie.com staff writersMRICalyx partners with Ceretype to offer AI in neuroimagingHealthcare information technology services provider Calyx Medical Imaging is partnering with Ceretype Neuromedicine to offer the company's functional MRI (fMRI) platform for the development of psychiatric and neurological therapies.April 4, 2023BreastMolli Surgical unveils two new offeringsBreast lesion marker technology firm Molli Surgical has expanded its offerings with the introduction of its Molli 2 and Molli re.markable products.April 3, 2023AssociationsACR secures highest CME accreditation statusThe American College of Radiology (ACR) has been awarded "Accreditation with Commendation" status by the Accreditation Council for Continuing Medical Education (ACCME).April 3, 2023UltrasoundFujifilm plans April release for new ultrasound systemFujifilm Healthcare will be releasing its Arietta 750 DeepInsight ultrasound system this month.April 3, 2023Image ProcessingTeraRecon expands Eureka with Radiobiotics dealAdvanced visualization and artificial intelligence (AI) software developer TeraRecon has formed a partnership with Danish AI software firm Radiobotics.April 3, 2023UltrasoundFDA clears Butterfly's handheld ultrasound for lung assessmentThe U.S. Food and Drug Administration (FDA) has cleared point-of-care ultrasound developer Butterfly Network's artificial intelligence-based handheld ultrasound device for lung health assessment.April 2, 2023Radiation Oncology/TherapyOrbit, Evergreen to collaborate on new radiopharmaceuticalsOrbit Discovery and Evergreen Discovery plan to collaborate on identifying cell-targeting peptides in order to develop new radiopharmaceuticals.April 2, 2023Image ProcessingTeraRecon adds oncology contouring to its Eureka AI platformConcertAI subsidiary TeraRecon has added Coreline Soft artificial intelligence (AI)-based oncology contouring to its Eureka clinical AI platform.April 2, 2023Nuclear MedicineAblaze secures peptide drug license from RayzeBioAblaze Pharmaceuticals has licensed a peptide drug candidate from RayzeBio that it will develop to target the liver cancer biomarker GPC3. Ablaze plans to market the new drug in China, where the company is headquartered.March 30, 2023MRISociety for Cardiovascular MR releases COVID-19 imaging recommendationsThe Society for Cardiovascular Magnetic Resonance (SCMR) has released a recommendation for cardiac magnetic resonance imaging of COVID-19, noting that the modality is an effective way to assess heart health in this population.March 30, 2023Previous PagePage 45 of 3774Next PageTop StoriesClinical NewsCloser proximity to Missouri's Coldwater Creek tied to cancer riskPeople who live or have lived near Coldwater Creek, Missouri, have a higher risk of developing cancer.AIChatGPT-4 accurately classifies pancreatic cysts on MRI, CT imagingCTVideo: SCCT president offers highlights for upcoming meetingCTCT reveals changes in lung holes in emphysema patientsSponsor ContentWhen time is of the essence